1 |
Tse E, Kwong YL. The diagnosis and management of NK/T-cell lymphomas[J]. J Hematol Oncol, 2017, 10(1): 85.
|
2 |
王颖超, 王龙, 殷楚云, 等. 儿童NK/T细胞淋巴瘤11例临床病理分析[J]. 中华肿瘤防治杂志, 2020, 27(5): 393-397.
|
|
Wang YC, Wang L, Yin CY, et al. Clinicopathological analysis of 11 cases of NK/T-cell lymphoma in children[J]. Chin J Cancer Prevent Treat, 2020, 27 (5): 393-397.
|
3 |
Liang R, Wang Z, Bai QX, et al. Natural killer/T cell lymphoma, nasal type: a retrospective clinical analysis in north-western China[J]. Oncol Res Treat, 2016, 39(1/2): 45-52.
|
4 |
Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms[J]. Blood, 2016, 127(20): 2375-2390.
|
5 |
Taali L, Abou-Elfadl M, Fassih M, et al. Nasal NK/T-cell lymphoma: a tragic case[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2017, 134(2): 121-122.
|
6 |
Jabbari Azad F, Delavarian Z, Hatami M, et al. Extranodal NK/T cell lymphoma with destruction of the uvulae: a case report[J]. Iran J Otorhinolaryngol, 2017, 29(91): 101-108.
|
7 |
Pd Vasconcelos, Ferreira C, Soares-Almeida L, et al. Multifocal primary cutaneous extranodal NK/T lymphoma nasal type[J]. An Bras Dermatol, 2016, 91(2): 219-221.
|
8 |
Kim JW, An JH. Extranodal natural killer/T-cell lymphoma, nasal type, of the orbit mimicking recurrent orbital cellulitis[J]. J Craniofac Surg, 2014, 25(2): 509-511.
|
9 |
Tang YL, Zhou Y, Cheng LL, et al. BCL2/Ki-67 index predict survival in germinal center B-cell-like diffuse large B-cell lymphoma[J]. Oncol Lett, 2017, 14(3): 3767-3773.
|
10 |
Hamada T, Nakamura S, Ko YH, et al. Epstein-Barr virus-associated T/natural killer-cell lymphomas in the elderly: the first consensus meeting in Kofu 2013[J]. J Dermatol, 2014, 41(1): 40-42.
|
11 |
Tian C, Wang Y, Zhu L, et al. Primary bone natural killer/T cell lymphoma, nasal type without EBV infection: a case report[J]. Int J Clin Exp Pathol, 2015, 8(11): 14836-14839.
|
12 |
Peng RJ, Han BW, Cai QQ, et al. Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma[J]. Leukemia, 2019, 33(6): 1451-1462.
|
13 |
Jeong SH, Song HN, Park JS, et al. Allogeneic stem cell transplantation for patients with natural killer/T cell lymphoid malignancy: a multicenter analysis comparing upfront and salvage transplantation[J]. Biol Blood Marrow Transplant, 2018, 24(12): 2471-2478.
|
14 |
Wang JW, Wei LQ, Ye J, et al. Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center[J]. Int J Hematol, 2018, 107(1): 98-104.
|
15 |
Harabuchi Y, Takahara M, Kishibe K, et al. Extranodal natural killer/T-cell lymphoma, nasal type: basic science and clinical progress[J]. Front Pediatr, 2019, 7: 141.
|
16 |
Zhou XX, Sun XG, Zhao WB, et al. Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma[J]. Cancer Manag Res, 2019, 11: 4243-4254.
|
17 |
Clarke CA, Morton LM, Lynch C, et al. Risk of lymphoma subtypes after solid organ transplantation in the United States[J]. Br J Cancer, 2013, 109(1): 280-288.
|
18 |
Wong DJY, Parry LA, Bloch AE, et al. Extranodal NK/T cell lymphoma, nasal type, with retrobulbar extraconal phlegmon and naso-oral fistula[J]. BMJ Case Rep, 2019, 12(3): e227160.
|